Pharma & Biotech
Lexaria Bioscience seeing increased demand for its DehydraTECH drug delivery system
Agile Therapeutics preps for commercialization of contraceptive skin patch Twirla
Acasti Pharma eyeing FDA meeting as it continues to advance heart disease candidate CaPre
Only registered members can use this feature.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.